We serve Chemical Name:5-(2-bromoethyl)-2,2-dimethyl-1,3-dioxane CAS:97845-58-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(2-bromoethyl)-2,2-dimethyl-1,3-dioxane
CAS.NO:97845-58-4
Synonyms:5-(2-bromoethyl)-2,2-dimethyl-[1,3]dioxane
Molecular Formula:C8H15BrO2
Molecular Weight:223.10700
HS Code:2934999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:239.2ºC at 760 mmHg
Density:1.255g/cm3
Index of Refraction:1.453
PSA:18.46000
Exact Mass:222.02600
LogP:2.17050
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NA 1993 / PGIII
Packing Group:
Contact us for information like 5-(2-bromoethyl)-2,2-dimethyl-[1,3]dioxane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-(2-bromoethyl)-2,2-dimethyl-[1,3]dioxane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(2-bromoethyl)-2,2-dimethyl-[1,3]dioxane Use and application,5-(2-bromoethyl)-2,2-dimethyl-[1,3]dioxane technical grade,usp/ep/jp grade.
Related News: The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 5-(2-bromoethyl)-2,2-dimethyl-1,3-dioxane manufacturer The entire set of results “strongly support” the Darzalex-Rd combo as a new standard of care for newly diagnosed, transplant-ineligible multiple myeloma patients, Thierry Facon, M.D., an investigator of the MAIA trial, said in a statement. 5-(2-bromoethyl)-2,2-dimethyl-1,3-dioxane supplier However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 5-(2-bromoethyl)-2,2-dimethyl-1,3-dioxane vendor Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access. 5-(2-bromoethyl)-2,2-dimethyl-1,3-dioxane factory Higher-risk MDS is a disease with significant unmet need, and we are pleased to be able to support healthcare professionals seeking access to rigosertib, ahead of its commercial launch,�� said Mark Corbett, EVP, Inceptua Medicines Access.
